ARTICLE | Clinical News
Lipoprotein-associated phospholipase A2 regulatory update
March 26, 2001 8:00 AM UTC
GlaxoSmithKline plc (GSK; LSE:GSK, London, U.K.) received U.S. Patent No. 6,177,257 covering the diagnosis of atherosclerosis susceptibility using antibodies against the Lp-PLA2 enzyme. diaDexus, the...